These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33570761)

  • 41. Atopic Dermatitis: A Heterogeneous Disorder.
    Silverberg JI; Silverberg NB
    Dermatol Clin; 2017 Jul; 35(3):ix-x. PubMed ID: 28577808
    [No Abstract]   [Full Text] [Related]  

  • 42. Outcome measures of disease severity in atopic eczema.
    Charman C; Williams H
    Arch Dermatol; 2000 Jun; 136(6):763-9. PubMed ID: 10871941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurodermatitis: endogenous eczema--atopic dermatitis--atopic eczema].
    Gropp U
    Kinderkrankenschwester; 1999 Mar; 18(3):91-5. PubMed ID: 10446533
    [No Abstract]   [Full Text] [Related]  

  • 44. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
    Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
    J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dermatological climatotherapy on the North Sea. Clinical-analytical studies of constitutional eczematoid with-without bronchial asthma and-or atopic rhinitis].
    Pürschel W
    Dermatologica; 1973; 146():Suppl 1:1-98. PubMed ID: 4268155
    [No Abstract]   [Full Text] [Related]  

  • 46. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
    Eichenfield LF; Tom WL; Chamlin SL; Feldman SR; Hanifin JM; Simpson EL; Berger TG; Bergman JN; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R
    J Am Acad Dermatol; 2014 Feb; 70(2):338-51. PubMed ID: 24290431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
    Schmitt J; Spuls P; Boers M; Thomas K; Chalmers J; Roekevisch E; Schram M; Allsopp R; Aoki V; Apfelbacher C; Bruijnzeel-Koomen C; Bruin-Weller M; Charman C; Cohen A; Dohil M; Flohr C; Furue M; Gieler U; Hooft L; Humphreys R; Ishii HA; Katayama I; Kouwenhoven W; Langan S; Lewis-Jones S; Merhand S; Murota H; Murrell DF; Nankervis H; Ohya Y; Oranje A; Otsuka H; Paul C; Rosenbluth Y; Saeki H; Schuttelaar ML; Stalder JF; Svensson A; Takaoka R; Wahlgren CF; Weidinger S; Wollenberg A; Williams H
    Allergy; 2012 Sep; 67(9):1111-7. PubMed ID: 22844983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.
    Tam HH; Calderon MA; Manikam L; Nankervis H; Núñez IG; Williams HC; Durham SR; Boyle RJ
    Allergy; 2016 Sep; 71(9):1345-56. PubMed ID: 27184158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
    Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
    Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment.
    Lloyd-Lavery A; Solman L; Grindlay DJC; Rogers NK; Thomas KS; Harman KE
    Clin Exp Dermatol; 2019 Jun; 44(4):376-380. PubMed ID: 30706507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies for Successful Management of Severe Atopic Dermatitis.
    Brar KK; Nicol NH; Boguniewicz M
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Objective measurements of disease severity and diagnostic confirmation in atopic dermatitis and urticaria].
    Mihara S
    Arerugi; 2012 Jan; 61(1):10-7. PubMed ID: 22398423
    [No Abstract]   [Full Text] [Related]  

  • 53. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
    Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of 'atopic dermatitis'.
    Kantor R; Thyssen JP; Paller AS; Silverberg JI
    Allergy; 2016 Oct; 71(10):1480-5. PubMed ID: 27392131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
    Hanifin JM; Thurston M; Omoto M; Cherill R; Tofte SJ; Graeber M
    Exp Dermatol; 2001 Feb; 10(1):11-8. PubMed ID: 11168575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
    Simpson E; Bissonnette R; Eichenfield LF; Guttman-Yassky E; King B; Silverberg JI; Beck LA; Bieber T; Reich K; Kabashima K; Seyger M; Siegfried E; Stingl G; Feldman SR; Menter A; van de Kerkhof P; Yosipovitch G; Paul C; Martel P; Dubost-Brama A; Armstrong J; Chavda R; Frey S; Joubert Y; Milutinovic M; Parneix A; Teixeira HD; Lin CY; Sun L; Klekotka P; Nickoloff B; Dutronc Y; Mallbris L; Janes JM; DeLozier AM; Nunes FP; Paller AS
    J Am Acad Dermatol; 2020 Sep; 83(3):839-846. PubMed ID: 32344071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eczema: causes, symptoms and treatment in the community.
    Peate I
    Br J Community Nurs; 2011 Jul; 16(7):324, 326-31. PubMed ID: 21727789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    Kido-Nakahara M; Yokote G; Yoshida M; Furue M; Nakahara T
    J Dermatol; 2021 Dec; 48(12):1951-1952. PubMed ID: 34580905
    [No Abstract]   [Full Text] [Related]  

  • 59. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.
    Chan S; Cornelius V; Chen T; Radulovic S; Wan M; Jahan R; Lack G
    Trials; 2017 Mar; 18(1):136. PubMed ID: 28330497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comment on: "When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council".
    Daunton A; Goulding JMR
    J Am Acad Dermatol; 2018 Aug; 79(2):e23-e24. PubMed ID: 30012283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.